Immunocore Historical Financial Ratios
| IMCR Stock | USD 29.00 0.80 2.68% |
Immunocore Holdings is lately reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 3.88 or Days Sales Outstanding of 70.43 will help investors to properly organize and evaluate Immunocore Holdings financial condition quickly.
Immunocore |
About Immunocore Financial Ratios Analysis
Immunocore HoldingsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Immunocore Holdings investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Immunocore financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Immunocore Holdings history.
Immunocore Holdings Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Immunocore Holdings stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Immunocore Holdings sales, a figure that is much harder to manipulate than other Immunocore Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Most ratios from Immunocore Holdings' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Immunocore Holdings current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.At this time, Immunocore Holdings' Cash Per Share is relatively stable compared to the past year. As of 03/11/2025, PFCF Ratio is likely to grow to 74.13, while PTB Ratio is likely to drop 3.88.
| 2022 | 2023 | 2024 | 2025 (projected) | |
| Days Sales Outstanding | 70.55 | 89.9 | 74.14 | 70.43 |
| PTB Ratio | 7.74 | 9.06 | 4.09 | 3.88 |
Immunocore Holdings fundamentals Correlations
Click cells to compare fundamentals
Immunocore Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunocore Holdings fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 33.37 | 40.53 | 15.01 | 13.39 | 4.75 | 4.52 | |
| Ptb Ratio | 18.16 | 6.27 | 7.74 | 9.06 | 4.09 | 3.88 | |
| Days Sales Outstanding | 24.86 | 341.88 | 70.55 | 89.9 | 74.14 | 70.43 | |
| Book Value Per Share | 1.74 | 4.04 | 6.1 | 7.54 | 7.22 | 7.58 | |
| Operating Cash Flow Per Share | (1.91) | (3.05) | (0.68) | 0.0601 | 0.52 | 0.55 | |
| Stock Based Compensation To Revenue | 0.27 | 1.84 | 0.23 | 0.13 | 0.11 | 0.1 | |
| Capex To Depreciation | 0.34 | 0.14 | 0.36 | 1.33 | 1.23 | 1.29 | |
| Pb Ratio | 18.16 | 6.27 | 7.74 | 9.06 | 4.09 | 3.88 | |
| Ev To Sales | 31.18 | 33.97 | 13.17 | 11.95 | 3.42 | 3.25 | |
| Free Cash Flow Per Share | (2.0) | (3.08) | (0.73) | (0.0508) | 0.42 | 0.44 | |
| Roic | (0.47) | (0.5) | (0.11) | (0.12) | (0.085) | (0.0892) | |
| Inventory Turnover | (3.53) | (3.9) | 0.48 | 0.23 | 0.5 | 0.53 | |
| Net Income Per Share | (2.33) | (3.1) | (0.9) | (1.13) | (1.02) | (1.07) | |
| Days Of Inventory On Hand | (103.26) | (93.67) | 758.14 | 1.6K | 727.86 | 764.25 | |
| Payables Turnover | 9.49 | 7.24 | 0.0314 | 0.0583 | 0.11 | 0.1 | |
| Research And Ddevelopement To Revenue | 2.48 | 2.76 | 0.62 | 0.66 | 0.72 | 0.68 | |
| Capex To Revenue | 0.1 | 0.038 | 0.0153 | 0.0217 | 0.0167 | 0.0158 | |
| Cash Per Share | 4.08 | 5.6 | 7.27 | 9.05 | 16.41 | 17.23 | |
| Pocfratio | (16.59) | (8.28) | (68.98) | 1.1K | 56.59 | 53.76 | |
| Interest Coverage | (27.72) | (23.25) | (5.15) | (11.57) | (3.74) | (3.93) | |
| Capex To Operating Cash Flow | (0.0507) | (0.007769) | (0.0703) | 1.85 | 0.2 | 0.19 | |
| Pfcf Ratio | (15.79) | (8.22) | (64.45) | (1.3K) | 70.6 | 74.13 | |
| Days Payables Outstanding | 38.45 | 50.45 | 11.6K | 6.3K | 3.4K | 2.9K | |
| Income Quality | 0.82 | 0.99 | 0.76 | (0.0678) | (0.51) | (0.48) | |
| Ev To Operating Cash Flow | (15.5) | (6.94) | (60.56) | 1.0K | 40.7 | 38.67 | |
| Pe Ratio | (13.56) | (8.17) | (52.32) | (60.41) | (28.87) | (30.31) | |
| Return On Tangible Assets | (0.38) | (0.49) | (0.0947) | (0.0926) | (0.0506) | (0.0531) | |
| Ev To Free Cash Flow | (14.75) | (6.89) | (56.58) | (1.2K) | 50.78 | 53.32 | |
| Net Debt To E B I T D A | 0.64 | 1.04 | 6.86 | 6.94 | 5.88 | 6.17 | |
| Current Ratio | 2.78 | 4.29 | 4.72 | 3.8 | 4.38 | 2.85 | |
| Tangible Book Value Per Share | 1.74 | 3.3 | 6.09 | 7.54 | 7.22 | 7.58 | |
| Receivables Turnover | 14.68 | 1.07 | 5.17 | 4.06 | 4.92 | 7.52 | |
| Shareholders Equity Per Share | 1.74 | 4.04 | 6.1 | 7.54 | 7.22 | 7.58 | |
| Debt To Equity | 1.15 | 0.37 | 0.25 | 0.23 | 0.12 | 0.11 | |
| Capex Per Share | 0.16 | 0.0967 | 0.0237 | 0.0481 | 0.11 | 0.1 |
Pair Trading with Immunocore Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immunocore Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Immunocore Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immunocore Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immunocore Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immunocore Holdings to buy it.
The correlation of Immunocore Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunocore Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunocore Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immunocore Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.